Stifel: Comparing US Cannabis To Traditional CPG Suggests ~20x Upside
On Monday Stifel GMP released their 2021 US Cannabis outlook. Andrew Partheniou, Stifel GMP’s cannabis analyst, headlines the note by … Continue reading Stifel: Comparing US Cannabis To Traditional CPG Suggests ~20x Upside
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
